Angiographic disease progression in patients with angina pectoris and normal coronary angiograms who are restudied due to unstable symptoms  by Cox, I.D. et al.
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The goal of this STRESS substudy was to compare PTCA and atontlng in pa- 
tients with UA, Of 598 patients enrolled in the STRESS I-II trial, 330 patients 
(55%) had UA (with angina at rest in 86%). Baseline characteristics were 
similar in the two tre~4ment groups. Procedural success (residual stenosls 
• ~50% and no meier nompllcatlon) was achieved in 80% of PTCA patients 
end 88% of stsni patients (p = 0,055), Reclosuro within 30 days occurred In 
1 3% after PTGA and 2,3% after slanting (p = as), QGA results (in mm) were: 
"rre~(ment Gro,p V~nl Dmmetar La~lon Length Pro MLD Peat MLD 6 me MLu 
Ang~pt~ty 2,07 A,t~ 0,76 1,97 1 A8 
Blent ~95 B.9 034 2.42 t ,(~8 
p NB N5 NB - 0,001 0,01 
Compared to PTCA. slanting wire ~ssoclntsd with significantly greater 
scum g~ln (1,21 v R 1,69 am, p - 0,001), Into loss (0,52 ve 0,70 am, 
p < 0,01), and net g~In (0,72 ve 0,03 am, p ~ 0,01), Restenosls was 47% 
(~5/117) ~fter PTCA and 35% (50/t45) after slanting (p ~ 0,04), T~rgei lesion 
rovalcularizatlon w~s performed In 25% of PTCA and 20% of slant patients 
(p., 0,19), This retrospective analysis from the STRESS trial suggests that 
st~nt placement provides superior angtogmphlo results to balloon anglopiasty 
in patients with LIA, Fudhsr prospective trials of slanting in the treatment o! 
acute I,~Ch~mlg ~yndrome~ nm warranted, 
~ l 'ranslant De©run of Thrembln Generat ion 
During Hlrudln 'l'matmont In Patl lnt= With Aaut~ 
Coronary Syndromes 
P,A, Madinl, D, Ardlsatno, K,A, Bauer, L, Oltmnn, M, Galvenl, F, Oftant, 
P,M, Mannu~l, R.D, Rossnbeqt, OlWslon of Carchol~, Ospeclate 
Ntg~rda, IRCCS FOre/irate S. Mart~o, Pavia. Italy: Beth Israel Hospital, 
8o~on, MA, USA 
In the acute phase ot acute coronary syndromes (ACS) heparln (H) is able 
to suppren Increased thrombln activity, as q¢ nntilled by llbrtnopeptlde A 
plasma levels (FPA) but not thrembtn genaraflon, aa indicated by prolhrombin 
fragment 1 + 2 (F~, ~), At drag termination It,ore Is a rebound increase 
in both markers, The eftect ot hlrudln (D on I=PA and Ft + ~ hea bo'~n 
lass investigated We measured plasma levels of F1 + 2 (RIA) and FPA 
(ELIZA) In 78 p~tlents with ACS receiving hopann or himdin in the GUSTO 
lib ~tudy, None el the patients received thmmbolyttc therapy. Coagulation 
activation markers wore measured et baseline (BL), after 3-5 days of drag 
administration Immediately before drag termination (1"), 3, 6 and 24 hours 
after drag termination, and after 1 month, Data are expressed as medians 
(interquadite ranges): 
FPA B T 3 h 6 h 24 h t me 
D 20 00" 1 1" 1 0 16 I 0' 
to 7-3 5~ (07-1 1) (e .q- 1 6) (105-341 (1 3-2 3) (0 ~1-1 3'1 
H 21 I I" 22 21 20 10" 
(I I~'-,12t (oa.10t (I 1-8e~ (1 1-491 (09-37) t08-12l 
F I+~ 
D 1,1 O05" 104 101 107 1,3' 
(003"1 4t tO 70-1 1) ~O 78-1 2t ~0185-1,2) t0 85-1 4) (1.12-1,8) 
H I O? 113 145' t 46" 137' 1 26" 
(O 8~,-1 4) (090-14) (1 12-~ 0) tl 06-2,0) (112-1.7) (O 94-1 7) 
"O" O 05 VS b~s0hno 
Thus, D induced significant decrease beth in thrembin generation and 
activity during treatment. After T there was a increase In thrombln generation 
and activity to baseline values in both D and H patients. Alter 1 month both 
groups showed a persistent elevated thrombin generation, The early clinical 
benefit shown by D during treatment in the GUSTO lib may be linked to more 
effective inhibition of thrembln generation. The loss of the tavourable ffect 
after T may be due to the persistently increased thmmbtn generation. 
• Dlfferent Thrombotic Inflammatory and Patterns 
Between Unstable Angina and Peripheral 
Vascular Dlsease 
C, Monaco, E, Rossi. D, Milazzo, G. Liuzzo, A. Cucuto, F. Citterio ~ ,
G, D'Onofrto ~ .W. van do Greet. A. Meg, L.M. BiasuccL A. MaserL 
Cardiology, Catholic Universi~ Rome. Italy: r Surge~ Catholic Universi~ 
Rome, Its:y: Hacmarology, Catholic University, Rome, Italy 
Backgrouod: Although Peripheral Vascular Disease (PVD) and acute coro- 
nary syndromes have a common athoresclerotic background, their clinical 
presentation and evolution are very different, raising the question whether 
they have similar or distinct pathogenetic mechanism. 
Methods: To this aim we studied C-Reactive Protein (CRP; an acute 
phase reactant), Myeloperexidase Intracellular Index (MPXh whose reduction 
lae marker of neutmphil activation; expressed in arbitrary ~nlts. AU) and 
D-Olmers (DO; hemoststlc system activation marker) tn 20 patients (pts) 
with PVD symptomatic for intermittent ¢laudicatton or mat pain but without 
cutaneous ulcerations (Stage Lertche.Fontame I1-111) with anglograltcally 
proven severe obstructions and thrombosis and 20 pie with unstable angina 
(UA) and stngto vessel disease and no clinical evldorce of PVD, 
Results: (median and range): PVD pts presented a greater activation of 
the hemostatl¢ system than UA pts (DD: 22 mlcrogr/L, 9,1 to 140, in PVD pts 
and 8,8 mlcrogr/L, 2,2 to 149, In UA pie; p - 0,006), However, CRP levels 
was sin'%, in both groups (4,2 mg/I., 0,8 to 24 in PVD pts and 0 mg,/L, t.40 
to 28 In UA pts; p - NS), In contrast, MPXI was significantly mck~'ed in UA 
than in PVD pta ( -4  AU, - t0  to 2,4, in UA pie and 1,0 AU, ~t~,5 to 6, in 
PVD pts; p - 0,02), 
Concl~dor~: In spite el a much smaller athero~¢!emtio and Ihmmhot~ 
burden. UA pts exhibit an acute phase response similar tO PVD pts and a 
significantly greeter n,'~utrophil activation, These til'tdin~},5 indicate that in,am. 
matory response in UA la largely unmlaled to severity of athoros¢lsmt~ and 
tt~mmbotta burden, 
~ ~  Iletweon a Very Low I~!Nular Compl r l son  
Weight Hol~r ln l ind Unf ru t loMted  I~par in  in 
Patients With Unstable Angina.  A Pilot 81udy 
AV, Maftlol(, L, Sermani, L, Ooedecke, R, Motinad, E,T, Castellani, 
G. Matttoll, Dpt ot Can~ Universtly ot Modena, Italy 
~ckgmund: Aim of the study was to compare the ettcecy el veq/ low 
molecular weight hepadn (VLMWH) combined with aspinn and standaf¢l 
heparm (SH) plus aepinn, duflng the acute phase of unstable angina, 
Melhods: One hundred and twenty patients (pts) with unstable angina 
were randomized to receive SH (dosage: bolus el 5,000 U,t. ldfownd by 
APTT control dose) plus aspldn t 00 rag/die (Group 1; 60 pts, mean age 69.12 
± 9,56) or VLMWH el the dosage of 150 mg for the first administratK~n a d 
than t 50 rag/die plus aspinn t00 mgtdie (Group 2; 60 pts, mean age 64.62 t 
I t ,0~), Pts were followed fOr 6 days, The meier end-peats detemned were: 
Death; Acute myocardial intsmtton (AMI); Recumant angina iRA) and Urgent 
raveecutsd=ation (UR), Minor end.point was =tent iechemia (St), E~t  rates 
~re  evaluated using ~ o analysis, Platelets were pemxfically checked dunng 
the in.hospital period. 
ResultS: ere shown in the table I. 
n . Evenls death AMI RA UR SI 
SH 60 26 O 2 ;20 3 t 
VLMWH 60 14 0 0 10 4 O 
p .  O.O05p, 005 
Events were significantly less frequent in pts treated with vlmwh (p 
0.005). During treatment he mean value ot platelets count decreased m 
patients treated with SH (p -: 0.05), no differences were obsen~l in VLMWH 
patients. 
I 1  2-1291 Disease Progress ion In Patients 21 Anglographlc With Angina Pectoris and Normal  Coronary 
Anglograms who Are Restudied due to Unstable 
Symptoms 
I.D, Cox, R, Schwartzman, F, Atienza, J,C. KaSkL St. George,s Hos~tal 
Medical School. London. UK 
Patients with chest pain and normal coronary angiograms have a favorable 
long-term prognosis but may be readmitted to hospital with symptoms and 
electrocardiographic hanges suggestive of unstable angina. The factors 
which may be associated with angiographic disease progression in such pa- 
tients are not tully understood. We investigated 139 consecutive patients with 
che~t pain and "normal" corunary angiograms, 101 patients had completely 
normal angiograms and 38 patients had minimal umenal irregularities (<20% 
sto: aDS(S). During a five year study period. 24 patients developed primaw un- 
stable angina and underwent repeat angiography. This group consisted of 19 
wet,ion and 5 men with a median age 56 years old (range 42 to 74 years). 
16 patients also had objective evidence of reversible ischaemia. The median 
intecval separating the angiograms was 58 months (range 8 to 130 months), 
At repeat angingraphy, none n! 21 restudied patients with cumpleteiy r,:~n'r ~' 
baseline angiograms had developed significant stenoses. In contrast, 2 of 
the 3 restudied patients with minimal irregularities at baseline had devet- 
ope,:J significant lesions (>50%). Both patients with progression also had left 
bundle branch block and more than one risk factor for coronary disease. 
However, the positive predictive accuracy of left bundle branch block (50%) 
wa~ greater than that for multiple risk factors (10%) in regard to angiographic 
disease progression. We conclude that angiographic progression in patients 
with chest pain and previously normal coronary aderiograms is unusual even 
JACC February. I()9~4 4~9A 
in the presence o! unstable symptoms. However, patients w~th minimal lu- 
menel irmgularibes at baseline angtography and/or loft bundle branch block 
may represent a sub-grou~ at incmas(~l risk 
11212-1301 Prognostk: Inflmmce of Mild Elevations of 
CaRIla¢ 11roponln I In Unstable Angina 
R,C, ~ ,  J, F~rrmm, J, Ftgu~ra, M Almeida, C, Agumf, T, Real, 
E, M~o.Gom~. R. Sea~a.Gom~. Oe~anmem o~ C ~  Sama Cruz 
IBlaOt.(~ut~d: Eleval~n~ Of cardiac ~ n ~  (Tn) ov~f an uppaf limit of 
mlewwce ( ~  Tn) seem~ to co~e~ an advmse P~iS  *n u ~  
en~m~ (UA), 
(;~cf~ve: We ~ to e,,amne me pmgnost~ ~t~,,--¢e of mid oleva. 
(~,0,00 and <OJ ngm~) ol Tnl m ~ w~t UA defim~d as chest 
pain at m~t ~ 24 h tmtk~.e hoS l ]~ ~ m¢ltm,N¢ ECG changes 
and normal CK (< 130 U&) and CK-MIB (.~ 16 U&) ovm the f~r~ ~4 ~ .  
~ I~ood ~ fo~ ca~tac ~ and Tnl m ~ 
at ~ on ~ ,  ~ 6 It0u~ ¢t~nn0 24 houm and 48 houm aftee 
~ ,  Serum Tnl was ~ by ~ ~  mmunuessay 
me,ted (~TtSan0~ Pastern). The I~maW endrm~ was the 30-Oay 
~ 01 death, m~ardzal ~ (MI). urgent myocantal 
rev~nzatmn f~ ~ ~l~em~ (U~gRev) o~ ~ a t m n  for 
Resu/Is: Fifteen pablmts pmsenle~J serial ~ (Gmt~p U~ Tnl 
w~h aB mea~.~ent~ntS E000 n{)~ 20 patler, ts had posttnm (Group P) Tnl 
w*th at least one measuremant :0.1 ~ and me mmammg 24 patents 
pmeeedmd todd elevalo~ (C~reup I~ ol Tnl. The pnma~ endpomt was 
ol~m~ed m 6.,"% el patie~s m Group U, m 37.5% m Group M and m 5(Po m 
Group P (p = 0.0~5). Tho fmque~-y ol d ined e~nls were: 
I o=, . , , .  I 
~ "  These data St~m~__ that Tni ts an important pe'o~rmst~ 
madm~r m pabet~s t~th UA. e,ven m Ihe I~resence o~ mkl e~ral~ons u~der the 
uppe~ kn'ut ol reference, usually ~ negatnre Tnl 
1212-135] uyoca~lal ~ In Patients W'IUl Spinal 
Cord Stimulation Assessed by Pos.mn 
Emission Tomography  
G. Zumt. 3. Mo~lia z, F. I~ Perle ~ , P Za~.  G. Pinato 4, G Nan ~ 
R. Buchbem~eF. A. ~ ~ . ' ~ ot Caro~ot~gy Mestre. Iraty: :One.on 
of Car~ Montebeltu.,~, Italy: ~Nuctear &~'rone Sennce C~nco 
Veneto~ Italy: ~ Pam Canter Mestre. traty 
Backgro~- Signal con1 stimulation (SCS) seems to be usual as a~luvant 
therapy in patients with intractable ang~ pe~ons not el@hie for myocardial 
~nzatK~n.  However the, mechamsn~ of its beneltoal effecls remain 
uncertain. Aim ol Our study was to asses I~e effects on myocardml perfusmn 
of SCS using positron en~ssmn tomography. 
Method: 11 pahez,~s (7 male, 4 female, mean age 75 + ~- 7 yrs) w~th chronic 
SCS (ITREL II and ,11 Med~omc) afte~r a mean pem.,d of 18 ÷-  16 months 
(range 2-.48) wero S'.dm~tEd tO 2 positron emLsston tomography ~ wtth 
13NH3 perfusion tracer:, the first one dunng SCS OFF for at least 20 hours, 
and the second or~e after 4 hours .,~th SCS ON. Ouantitatn~e evalualmn of 
myocardial blood flow was pedormod wdh Patfak graphic analysis. 
Results: Myecard~al blood flow w~th SCS ON increased from a mean value 
of 0.76 +-  0.23 mVmiNg to a mean value of 0.89 + - 0.23 ml/min/g (p = NS). 
However myocardial blood flow increased in 9 pts (from 0.660.16 mL/n'~n/g 
1o 0.87 +-  0.24 ml/min/g: p < 0.05) and decreased in 2. It is remarkable that 
in the last 2 pts myocardial basal flow was abnormally high (1 38 and 1.02 
ml/min/g respectively). 
Conclusion: this study suggest that the beneficial effect of SCS in m- 
tractable angina pectoris may be related to an increase of myocardial blood 
flow. 
I1 71 ~-1 3P.. [ The Inf luence of Left Bundle Branch Prognost ic  
f Block in Unstable Angina 
M. Farkouh, M. Allen, G. Reeder, P. Smars, S Gabriel, A. Zinsmeister. 
Mayo Clinic, Rochester, MN, USA 
The presence of left bundle branch block (LBBB) in patients presenting with 
acute chest pain consistent with unstable angina represents a diagnostic 
challenge to clinicians. 
Aim To assess the pro~¢ vslu~ o! UBBB over and above 1he e=~0 
AHCPR guidelines for uns~t)le a~lma 
Mol/xx/s: A community cohort of patNmts pm~mntmg to a toc~l ER 0unng 
1985--1992 with symptoms COnSistent ~ unstablo angina W~~ f0{lOwf~ 
thin ¢omplet6 ir~tient and oulpat~nt ~ records Thor l:~t~ant,ng 
ctinlca! v~rklble_s at ER tn~ visit were ~ to clet~fy th~f AHCPR nsk 
slrattm. Subaequ~m ca~a~u!~f  oulcomel (MI, deam, CHF, ¢a~¢ at. 
re~t. t~Ifgke) were n ~  I~M~ 1 ~.  A Io~pel~ ~ wM ~ed 
to asz~ul! the PmgnOalm value of the prelNmce of UBBB on ftle iLm~scm'm~g 
EGG fo~ the CV ~ in the hint 30 (tay~ afle~ pmsantatton d j~g ~ 
i~ .  g~k~.  AHCPR rtsk Clam ~ the pfe6ence of abnot, lmal EC~ ~mdady, 
a ~t r~ l  ~ |  ha=~zl~ ~egre~ anaty~_ ewluale~ t~ to f~l  
CV event. 
R~4dt=: A total of 13B5 ¢ommun~ ~lml I  wef~ foffowe¢l tot a median 
of 5.4 yearn and only 12 (1%) ~ Io~ to lollowup before 30 d=ys LBBB 
wa~ ~ ~ w~h sho~ (p ~ 0.0~) and tong (p < 0001) te~ 
~ m  a~er mliuSlmg 1~' age, ~r ,  AHCPR flsk class and the presence 
ot al~qon~! ECG. The ~kwv~g ~ show~ tho ns~ ~o~ CV evant~ aceommg 
to we~entmg ECG: 
EK(}group|n) %HR %lR  30~ayevems OR RR 
Normal lT39) 12 ~6 34  m! ml 
AtOnEKG(579) 25 ~8 16 6 346 ! 04 
LB0~I55) 40 5~ 20 292 2 21 
HR = ~ fl~k IR = mfel111¢=~e r~k. OR = o¢ll0s ratio RR = ha~afO fallO 
Conclusion: LBBB m an impo~lan! leclor in nsk stratd~cat~on a d should 
be irm~q~orated into t.mstahle arr~ne gu¢lelmas 
Medical Therapies for Acute MyocanJlal 
InforcUon 
Wednesday, Apdl 1, 1998, 3:00 p.m.-5:00 p.m. 
Georgia World Congress Center, West Exhibit Hall Level 
Presentation Hour:. 4:00 p.m.-5:00 p.m. 
i 1213"1491 ~ With G,w,v-to-Needle Time= 
b~ea=~ the ~ of ~q~=mpda~ 
Thmmboly~ ~py in Patient= With 
Acu~ ~=¢am'~l mmmUon 
A Ketion. A. Ba,.tnm~ M. ShahL J. Bell Cardmtogy Department, Battle 
Hospnal. Rea~r~ Barks, UK 
Background. Optimal management of acute myocar~al mlerc~on (MI) re- 
qu~re~ a~ms~atmn of ~ therapy as soon as possdote, but the 
beneM appfles only to patents who fulfil spectf~ cntena. We have employed 
an aggress;ve pohcy to reduce ho~al  door-to-needle tm~=s since 1993 We 
mves~ted whether ~ls as]preach as affected Ihe accuracy Of adminislra- 
t~n ol m ~ s .  
Mett~o/s: Patmt'lls admitted wtlh MI. or who were thmmbolysed, Oct 
91-Jan 92 (66 Mls) were compared with those admitted Oct 94-Jan 95 (76 
MIs). MI was defined as 2/3 of ~ fotle~ng: >20 rain chest pmn; new Q 
waves or persmtent T wave changes in the ECG; peak CK >x2 upper limit of 
normal. Pat~qts were conspired el~ble for throml~01y~s it they had 
admmEd ~,mm 12 nou~ of It~e o,.~mt 01 pare. had no ~ t m ~ .  and 
the admissmn ECG stm~ed ST eleval~n of new LBBB 
Resu~s: The mean age (SD) of patie~s admitted w~th MI increased from 
65 (11) years to 70 (11) years (P = 002) The mean (SD) door.to-neeole 
time for al! pa~ents who recew~KI ~rombotysm on admis.~on d~cre~:l 
from 61 ('10t to 19 (20) minutes (P = 0.0004). The pmtx)rt~0n of patients 
eligible for thromlx~s who receded treatment increased from 24/38 (63=/0) 
to 30'30 (100%) (P = 0,0002). However, the proporlion of pa1~ents receNtng 
thrombotysis who d~d not fulfill our cntena also increased, from 3/27 (11%) !o 
11/41 (27%) (P = 0,1). 
Conctu~ons S.-t:,;e measures greatfy reduced door-to~eeole ,~mes and 
led to a higher propo~on of eligible patients recetving thremholysis. How, 
ever. greater pressure on medical slaff to make rap~d management dec~stons 
increased the proportton of patients b~tng thrombolysecl mappropnately. This 
may dilute arx. potentmt benefit achieved by aggressively reduong door-to- 
needle times. 
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